Package 72865-171-01

Brand: hydromorphone hydrochloride

Generic: hydromorphone hydrochloride
NDC Package

Package Facts

Identity

Package NDC 72865-171-01
Digits Only 7286517101
Product NDC 72865-171
Product ID 72865-171_55fb6272-5677-43cf-b92d-5a6a6f484b6e
Description

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-171-01)

Marketing

Marketing Status
Marketed Since 2020-09-24
Brand hydromorphone hydrochloride
Generic hydromorphone hydrochloride
Sample Package No

Linked Drug Pages (1)

hydromorphone hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "55fb6272-5677-43cf-b92d-5a6a6f484b6e", "openfda": {"upc": ["0372865168011", "0372865171011", "0372865170014", "0372865169018"], "unii": ["L960UP2KRW"], "rxcui": ["902729", "902736", "902741", "1306898"], "spl_set_id": ["90bda45c-9dbe-4ed5-91d0-df8446ad7026"], "manufacturer_name": ["XLCare Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-171-01)", "package_ndc": "72865-171-01", "marketing_start_date": "20200924"}], "brand_name": "hydromorphone hydrochloride", "product_id": "72865-171_55fb6272-5677-43cf-b92d-5a6a6f484b6e", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Full Opioid Agonists [MoA]", "Opioid Agonist [EPC]"], "product_ndc": "72865-171", "dea_schedule": "CII", "generic_name": "hydromorphone hydrochloride", "labeler_name": "XLCare Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "hydromorphone hydrochloride", "active_ingredients": [{"name": "HYDROMORPHONE HYDROCHLORIDE", "strength": "32 mg/1"}], "application_number": "ANDA212133", "marketing_category": "ANDA", "marketing_start_date": "20200924", "listing_expiration_date": "20261231"}